Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Vitasora Health Limited is a health technology company specializing in connected care management and remote patient monitoring, with operations in Australia and the United States. The firm develops, produces, and commercializes medical devices and e-health software solutions, most notably for respiratory condition management. Among its core products are mobile health applications, such as wheezo—a device capable of detecting and monitoring wheeze in patients with asthma, COPD, and other respiratory illnesses—and the Respiri mobile application, complemented by an integrated health portal for clinicians. In recent years, Vitasora Health has evolved from a focus solely on respiratory care to a broader, data-driven model supporting chronic disease management across multiple conditions, including cardiovascular disease, diabetes, and obesity. The company emphasizes multi-device integration, virtual clinical support, and AI-enhanced decision-making, enabling healthcare providers to extend care beyond the clinical setting while enhancing patient engagement and compliance. Vitasora Health collaborates with healthcare organizations, payers, and Accountable Care Organizations to deliver tailored, scalable solutions aimed at improving patient outcomes and supporting value-based care models. Incorporated in 1987 and headquartered in Melbourne, the company was formerly known as Respiri Limited, reflecting its origins in respiratory health.